No Picture
News

Forge Therapeutics Receives Notice Of Allowance From U.S. Patent And Trademark Office Covering Novel Chemistry Targeting LpxC For The Treatment Of Gram-Negative Bacterial Infections

-Issuance of patent demonstrates utility of Forge’s BLACKSMITH chemistry platform-

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ — Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel medicines targeting metalloenzymes, announced today… […]

No Picture
News

Forge Therapeutics Receives Notice Of Allowance From U.S. Patent And Trademark Office Covering Novel Chemistry Targeting LpxC For The Treatment Of Gram-Negative Bacterial Infections

-Issuance of patent demonstrates utility of Forge’s BLACKSMITH chemistry platform-

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ — Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel medicines targeting metalloenzymes, announced today… […]

No Picture
News

Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with New Patent Allowances in Europe and Canada

Patent allowances cover various aspects of the Company’s phage program and lead product candidate, AP-SA01Company to host bacteriophage Key Opinion Leader meeting and live webcast on Wednesday, June 26

MARINA DEL REY, Calif., June 3, 2019 /PRNewswire… […]

No Picture
News

Trovagene Announces New Patent Issued for Combination of Onvansertib with Anti-Androgen Drugs to Treat Non-Metastatic and Metastatic Prostate Cancer

Broad patent covers anti-androgen or androgen antagonist drugs, including combination treatment with Zytiga®, Xtandi® and Erleada® in multibillion-dollar marketCombination may enhance efficacy and increase duration of response to current therapies

S… […]

No Picture
News

Qualigen obtains exclusive license to novel cancer drug technology from Advanced Cancer Therapeutics

Qualigen continues to strengthen its cancer drug technology portfolio

CARLSBAD, Calif., Dec. 18, 2018 /PRNewswire/ — Qualigen, Inc., and Advanced Cancer Therapeutics, LLC (ACT) today announced that Qualigen has licensed certain ACT patents, intellec… […]